Copy number variations (CNVs) have been linked to several human neuropsychiatric conditions, including schizophrenia, epilepsy, and autistic spectrum disorders. How can you apply this insight to uncovering the underlying mechanisms of these conditions and developing effective treatments?
This webinar discusses the role of CNVs in disorders of cognitive development and how CNV mouse models support investigation of unsolved mysteries in psychiatric disease.
Dr. Michael Didriksen, Lead Scientist at H. Lundbeck A/S, leads and coordinates preclinical schizophrenia and psychosis research projects focusing on bridging preclinical and clinical schizophrenia and psychosis science.Dr. Didriksen will introduce three novel CNV mouse models carrying high-risk copy number variants 1q21.1, 15q13.3, and 22q11.2, which are all associated with increased risk of developing neuropsychiatric disease.
© 2021 Taconic Biosciences, Inc. All rights reserved.